Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinagolide versus oral contraceptive control for symptomatic grade III/IV endometriosis
2012-001789-13Phase 3Active
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quinagolide in endometriosis (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoint: Nerve fiber density. Started Sep 2012; status: active.
02
Drugs
quinagolide
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2012-001789-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001789-13.